HLA-B27 and ankylosing spondylitis;HLA-B27 ved bekhterevs sykdom

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 11, 2000, Pages 1317-1322

  Ulvestad, Elling ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

ANKYLOSING SPONDYLITIS; BIOLOGICAL MODEL; CD8+ T LYMPHOCYTE; CYTOTOXICITY; FLOW CYTOMETRY; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; PROGNOSIS; REVIEW;

CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HISTOCOMPATIBILITY TESTING; HLA-B27 ANTIGEN; HUMANS; MODELS, IMMUNOLOGICAL; PROGNOSIS; SPONDYLITIS, ANKYLOSING;

EID: 0034732397     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 287-99.
2. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992; 70: 1035-48.
3. Pei R, Arjomand-Shamasai M, Deng CT, Cesbron A, Bignon JD, Lee JH. A monospecific HLA-B27 flurosescein isothiocyanate-conjugated monoclonal antibody for rapid, simple and accurate HLA-B27 typing. Tissue Antigens 1993; 41: 200-3.
4. Neumüller J, Schwartz DWM, Dauber E, Mayr WR. Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT). Cytometry 1996; 26: 209-15.
5. Frankenberger B, Breitkopf S, Albert E, Scholz S, Keller E, Schattenkirchner M et al. Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B*2702 frequency in ankylosing spondylitis. J Rheumatol 1997; 24: 899-903.
6. Lopez de Castro JA. The pathogenetic role of HLA-B27 in chronic arthritis. Curr Opin Immunol 1998; 10: 59-66.
7. Brewerton DA, Hart FD, Nicholls A. Ankylosing spondylitis and HL-A27. Lancet 1973; 1: 904-7.
8. Suarez-Almazor ME, Russell AS. B27 homozygosity and ankylosing spondylitis. J Rheumatol 1987; 14: 302-4.
9. Rubin LA, Amos CI, Wade JA, Martin JR, Bale SJ, Little AH et al. Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompability complex region. Arthritis Rheum 1994; 37: 1212-20.
10. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997; 40: 1823-8.
11. Gran JT. Årsaksforhold ved Bekhterevs sykdom. Tidsskr Nor Lægeforen 1998; 118: 4537-40.
12. Aho K, Ahvonen P, Lassus A, Sieyers K, Tiilikainen A. HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease. Arthritis Rheum 1974; 17: 521-6.
13. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995; 38: 499-505.
14. Hermann E, Yu DT, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27-resrricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993; 342: 646-50.
15. Fiorillo MT, Meadows L, D'Amato M, Shabanowitz J, Hunt DF, Appella E et al. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur J Immunol 1997; 27: 368-73.
16. Khare SD, Luthra HS, David CS. HLA-B27 and other predisposing factors in spondyloarthropathies. Curr Opin Rheumatol 1998; 10: 282-91.
17. Zhou M, Sayad A, Simmons WA, Jones RC, Maika SC, Satumtira N et al. The specificity of peptides bound to human histocompability leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. J Exp Med 1998; 188: 877-86.
18. Ikawa T, Ikeda M, Yamaguchi A, Tsai WC, Tamura N, Seta N et al. Expression of arthritis-causing HLA-B27 on Hela cells promotes indution of c-fos in response to in vitro invasion by Salmonella typhimurium. J Clin Invest 1998; 101: 263-72.
19. Maksymowych WP, Ikawa T, Yamaguchi A, Ikeda M, McDonald D, Laouar L et al. Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27. Infect Immun 1998; 66: 4624-32.
20. Virtala M, Kirveskari J, Granfors K. HLA-B27 modulates the survival of Salmonella enteritides in transfected L cells, possibly by impaired nitric oxide production. Infect Immun 1997; 65: 4236-42.
21. Calin A. HLA-B27: to type or not to type? Ann Intern Med 1980; 92: 208-11.
22. Glennas A, Kvien TK, Melby K, Overboo A, Andrup O, Karstensen B et al. Reactive arthritis: a favorable 2 year course and outcome, independent of triggering agent and HLA-B27. J Rheumatol 1994; 21: 2274-80.
23. - disease. Scand J Rheumatol Suppl 1990; 37: 111-9.
24. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med 1981; 94: 553-600.
25. van der Linden S. Ankylosing spondylitis. I: Kelley WN, Harris ED, Ruddy S, Sledge CB, red. Textbook of rheumatology. 5. utg. Philadelphia: Saunders, 1997: 969-82.
26. Baron M, Zendel I. HLA-B27 testing in ankylosing spondylitis: an analysis of pretesting assumptions. J Rheumatol 1989; 16: 631-4.
27. Fryback DG. Bayes' theorem and conditional nonindependence of data in medical diagnosis. Comput Biomed Res 1978; 11: 423-34.
28. Greenland S. Probability logic and probabilistic induction. Epidemiology 1998; 9: 322-32.
29. Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum 1993; 22: 319-34.
30. Gran JT. An epidemiological survey of the signs and symptoms of ankylos ng spondylitis. Clin Rheumatol 1985; 4: 161-9.
31. Sandström J, Andersson GBJ, Rydberg L. HLA-B27 as a diagnostic screening tool in chronic low back pain. Scand J Rehab Med 1984; 16:27-8.
32. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977; 237: 2613-4.
33. Sober E. Philosophy of biology. Oxford: Oxford University Press, 1993.
34. Khan MA. Uten tittel. J Rheumatol 1989; 16: 634-6.
35. Gran JT, Husby G. HLA-B27 and spondyloarthropathy: value for early diagnosis? J Med Genet 1995; 32: 497-501.